Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

E-GNOSIS

Financiado

Cerrado

e Gnosis a novel platform technology for quantitative mobile diagnostics

The aim is to produce a platform technology that combines the price-point and ease-of–use of lateral flow immunoassays with high-sensitivity, quantitative measurements currently requiring capital intensive equipment. This could ul... ver más

30/07/2016

SINTEF

231K€

Presupuesto del proyecto: 231K€

Líder del proyecto

SINTEF AS No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-07-30 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

SINTEF

0.00€ | Lider

Proyectos interesantes

Nanozymes POC

Medical Technol...

Nanotechnology

149K€ Cerrado

MAT2012-38573-C02-02

Medical Technol...

Nanotechnology

112K€ Cerrado

MAT2011-29335-C03-03

Medical Technol...

Nanotechnology

30K€ Cerrado

TEC2012-34280

Medical Technol...

Nanotechnology

138K€ Cerrado

PEPTIDE NANOSENSORS

Medical Technol...

Nanotechnology

219K€ Cerrado

PTQ-15-07590

Medical Technol...

Nanotechnology

84K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

SINTEF AS No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 231K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The aim is to produce a platform technology that combines the price-point and ease-of–use of lateral flow immunoassays with high-sensitivity, quantitative measurements currently requiring capital intensive equipment. This could ultimately allow its use as a consumer-technology, to diagnose and monitor health. e-Gnosis is an interdisciplinary project combining the current state-of-the-art in recessed ring-disk nanoelectrode arrays with a novel signal amplification strategy in the form of ferrocene loaded pH sensitive polymer nanobeads. e-Gnosis will combine these technologies to produce a multiplexed biosensor chip capable of running several ultra-high sensitivity immunoassays without the need for complex or expensive read-out equipment. The use of nanostructured electrode arrays allows the local pH to be changed electrochemically, such that the pH sensitive beads bound to the analyte dissolve and release ferrocene, leading to a large, proportional signal amplification of each binding event. Amplification can be triggered without external reagent addition and, importantly, without necessitating a wash step to remove unbound labels (the rapid initial current peak is bound to originate from within the nanostructures). Performance characteristics will include low sample volume requirement, sensitivity, limit of detection, robustness to interferrents, dynamic range and speed to result. Fabrication is based on highly parallel semiconductor fabrication technology and standard methods for antibody immobilisation, allowing low cost production. The e-Gnosis platform can also be used for other affinity based recognition events. Apart from the potential commercial and societal benefits of such a sensing technology, the project will also produce two enabling methods within nanofabrication and surface functionalisation. The project feeds into key areas identified by EU and industry stakeholders within ETP Nanomedicine and Horizon 2020, amongst others.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores